Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (258)	7/17/2003 12:45:50 AM
From: Miljenko Zuanic	Read Replies (1) of 590

<< I think it is more probable that it is a new target they are talking about.>> I somehow agree. <<Would they btw. be able to collect a new milestone if it was the same target (i.e. a back-up mAb replacing a failed one).>> Yes, I think so. This is not development collaboration, so every time partner move candidate into human trials they should collect milestone. It will be nice to know what is PFE doing with first candidate. Maybe they are happy with it, so more confidence with next one??? :) Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next